American Journal of Ophthalmology
Volume 146, Issue 5 , Pages 631-634 , November 2008

Thrombolysis for Acute Central Retinal Artery Occlusion: Is it Time?

  • Valérie Biousse

      Affiliations

    • Corresponding Author InformationInquiries to Valérie Biousse, Neuro-ophthalmology Unit, Emory Eye Center, 1365-B Clifton Road, NE, Atlanta, GA 30322

,Accepted 14 July 2008.

References 

  1. Biousse V, Calvetti O, Bruce BB, Newman NJ. Thrombolysis for central retinal artery occlusion. J Neuroophthalmol. 2007;27:215–230
  2. Hayreh SS, Zimmerman MB. Central retinal artery occlusion: visual outcome. Am J Ophthalmol. 2005;140:376–391
  3. Brown GC. Retinal arterial obstructive disease. In:  Ryan SJ editors. Retina. St Louis, Missouri: Mosby; 1994;p. 1361–1377
  4. Ivanisevic M, Karelovic D. The incidence of central retinal artery occlusion in the District of Split, Croatia. Ophthalmologica. 2001;215:245–246
  5. Adams HP, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation. 2007;115:e478–e534
  6. Higashida RT, Furlan AJ, Roberts H, et al. Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology, Technology Assessment Committee of the Society of Interventional Radiology Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke. 2003;34:e109–e137
  7. Mattle HP. Intravenous or intra-arterial thrombolysis? (It's time to find the right approach for the right patient). Stroke. 2007;38:2038–2040
  8. Shaltoni HM, Albright KC, Gonzales NR, et al. Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke?. Stroke. 2007;38:80–84
  9. Noble J, Weizblit N, Baerlocher MO, Eng KT. Intra-arterial thrombolysis for central retinal artery occlusion: a systematic review. Br J Ophthalmol. 2008;92:588–593
  10. Hattenbach LO, Kuhli-Hattenbach C, Scharrer I, Baatz H. Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in central retinal artery occlusion. Am J Ophthalmol. 2008;146:700–706
  11. Aldrich EM, Lee AW, Chen CS, et al. Local intraarterial fibrinolysis administered in aliquots for the treatment of central retinal artery occlusion: the Johns Hopkins Hospital experience. Stroke. 2008;39:1746–1750
  12. Hayreh SS. Intra-arterial thrombolysis for central retinal artery occlusion. Br J Ophthalmol. 2008;92:585–587
  13. Suri MF, Nasar A, Hussein HM, et al. Intra-arterial thrombolysis for central retinal artery occlusion in United States: Nationwide In-patient Survey 2001–2003. J Neuroimaging. 2007;17:339–343
  14. Feltgen N, Neubauer A, Jurklies B, et al. EAGLE Study Group Multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications (EAGLE Study Report No. 1). Graefes Arch Clin Exp Ophthalmol. 2006;244:950–956
  15. Hayreh SS, Zimmerman MB, Kimura A, et al. Central retinal artery occlusion (Retinal survival time). Exp Eye Res. 2004;78:723–736
  16. Margo CE, Mack WP. Therapeutic decisions involving disparate clinical outcomes: patient preference survey for treatment of central retinal artery occlusion. Ophthalmology. 1996;103:691–696

 See accompanying Article on page 700.

PII: S0002-9394(08)00577-1

doi: 10.1016/j.ajo.2008.07.025

American Journal of Ophthalmology
Volume 146, Issue 5 , Pages 631-634 , November 2008

Article Tools